These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25033414)

  • 1. Should β-blockers be used in septic shock?
    Lira A; Pinsky MR
    Crit Care; 2014 May; 18(3):304. PubMed ID: 25033414
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for β-blockade in septic shock?
    Pinsky MR
    JAMA; 2013 Oct; 310(16):1677-8. PubMed ID: 24108438
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-acting β-blocker administration in patients with septic shock.
    Lin GM
    JAMA; 2014 Feb; 311(7):737. PubMed ID: 24549559
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-acting β-blocker administration in patients with septic shock.
    Bouglé A; Mira JP
    JAMA; 2014 Feb; 311(7):736-7. PubMed ID: 24549558
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-acting β-blocker administration in patients with septic shock.
    Sanfilippo F; Santonocito C; Maybauer MO
    JAMA; 2014 Feb; 311(7):736. PubMed ID: 24549557
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-acting β-blocker administration in patients with septic shock.
    Cortés DO; Taccone FS; Vincent JL
    JAMA; 2014 Feb; 311(7):735-6. PubMed ID: 24549556
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-acting β-blocker administration in patients with septic shock--reply.
    Morelli A; Ertmer C; Singer M
    JAMA; 2014 Feb; 311(7):737-8. PubMed ID: 24549560
    [No Abstract]   [Full Text] [Related]  

  • 8. YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.
    Kulkarni HS; Guzy RD; McEvoy C
    Am J Respir Crit Care Med; 2014 May; 189(9):1138-40. PubMed ID: 24787067
    [No Abstract]   [Full Text] [Related]  

  • 9. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. A letter to the authors.
    Zante B; Wirtz S
    Wien Klin Wochenschr; 2013 Jan; 125(1-2):54-5. PubMed ID: 23224411
    [No Abstract]   [Full Text] [Related]  

  • 10. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Reply to a letter to the authors.
    Balik M; Rulisek J; Leden P; Zakharchenko M; Otahal M; Bartakova H; Korinek J
    Wien Klin Wochenschr; 2014 Apr; 126(7-8):246-7. PubMed ID: 24343046
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
    Morelli A; Ertmer C; Westphal M; Rehberg S; Kampmeier T; Ligges S; Orecchioni A; D'Egidio A; D'Ippoliti F; Raffone C; Venditti M; Guarracino F; Girardis M; Tritapepe L; Pietropaoli P; Mebazaa A; Singer M
    JAMA; 2013 Oct; 310(16):1683-91. PubMed ID: 24108526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esmolol for septic shock: more than just heart rate control?
    Orbegozo Cortes D; Njimi H; Dell'Anna AM; Taccone FS
    Minerva Anestesiol; 2014 Feb; 80(2):254-8. PubMed ID: 24500140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
    Morelli A; Singer M; Ranieri VM; D'Egidio A; Mascia L; Orecchioni A; Piscioneri F; Guarracino F; Greco E; Peruzzi M; Biondi-Zoccai G; Frati G; Romano SM
    Intensive Care Med; 2016 Oct; 42(10):1528-1534. PubMed ID: 27101380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock.
    Balik M; Rulisek J; Leden P; Zakharchenko M; Otahal M; Bartakova H; Korinek J
    Wien Klin Wochenschr; 2012 Aug; 124(15-16):552-6. PubMed ID: 22815003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
    Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
    J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial blood pressure and heart rate regulation in shock state.
    DellaVolpe JD; Moore JE; Pinsky MR
    Curr Opin Crit Care; 2015 Oct; 21(5):376-80. PubMed ID: 26263297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-1 blockade in sepsis: what to expect?
    Enkhbaatar P
    Crit Care Med; 2013 Sep; 41(9):2237. PubMed ID: 23979375
    [No Abstract]   [Full Text] [Related]  

  • 18. Diltiazem versus esmolol for acute rate control in the emergency department.
    Harvey S; Wilson K; Brad Hall A
    Am J Emerg Med; 2017 Nov; 35(11):1760-1762. PubMed ID: 28465013
    [No Abstract]   [Full Text] [Related]  

  • 19. Action and Reaction: The Role of Catecholamine Agonists and Antagonists in Septic Shock.
    Freebairn R
    Crit Care Med; 2015 Sep; 43(9):2039-40. PubMed ID: 26274717
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful management of persistent tachycardia using esmolol in 2 dogs with septic shock.
    Beer KS; Balakrishnan A; Hart SK
    J Vet Emerg Crit Care (San Antonio); 2019 May; 29(3):326-330. PubMed ID: 31044499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.